Skip to main content
. 2013 Sep 11;22(5):610–616. doi: 10.1038/ejhg.2013.197

Table 1. Hormone data of patients.

Pt. 17OHP (ng/dl) D4A (ng/dl) F (ng/ml) T (ng/ml) 11-S (ng/ml)a DOC (ng/ml)a ACTH (pg/ml)
2 1811148 (10–143→104–488) 426473 (10–81→17–146) 122→172 (39–218→169–365) 0.5 (<0.10–0.37) 24.58b (0.09–1.09) 0.84b (<0.15)
3 248a (41.2–295.4) 288a (0.28–1.64) 182a (47.4–199.7) 0.3a (0.10–0.45) 2.94s (< 1.08) 3.24s (<0.12)
4 230 (<600) 85 (40–150) 1.7 (0.36–0.58) 7.54b (0.08–0.84) 333 (5–60)
5 2430 (<600) 1400 (<1.46) 1.8 (0.36–0.58) 9.51b (0.28–1.64) 329 (5–60)

Hormone data of patient 1 before treatment were not available.

Baseline→ACTH-stimulated hormone concentrations; reference intervals in parentheses; Bold characters refer to hormonal levels out of reference intervals.

a

Performed with ID-LC-MS/MS.

b

Assayed at a different time than other hormones.